L-Histidine
L-Histidine is an essential amino acid and the precursor to histamine and to the muscle buffer carnosine.
L-Histidine at a Glance
L-Histidine is an essential amino acid whose distinguishing feature is an imidazole side chain — able to gain or lose a proton right at physiological pH. That single property makes it a workhorse in enzyme active sites, in pH buffering, and in metal handling, and it is the reason histidine turns up in so many unrelated-looking places.
It is best known as the precursor to histamine and as a building block of the muscle dipeptide carnosine.
The through-line across its evidence is a repletion-versus-extra distinction. Histidine matters most where plasma levels are genuinely low — obesity with metabolic syndrome, chronic kidney disease — and much less where people are already replete. Standalone supplementation is uncommon, studied doses cluster around 4 g/day, and the strongest human signals come from a small number of trials rather than a deep, replicated literature.
What It’s Used For
- Insulin resistance & metabolic syndrome — one well-designed RCT, in women who started with low histidine.
- Atopic dermatitis (eczema) — two small placebo-controlled pilots, with a filaggrin mechanism behind them.
- Anemia & oxidative stress in CKD — observational, and deficiency-dependent.
- Antioxidant / oxidative-stress support — mechanism and animal work, no human endpoint trial.
The muscle-buffering claim needs correcting. Histidine does feed carnosine synthesis, but β-alanine — not histidine — is the rate-limiting substrate. Adding histidine does not meaningfully raise muscle carnosine in replete people.
And one clean failure: L-histidine was tested in rheumatoid arthritis at 4.5 g/day for 30 weeks in a double-blind RCT, and showed no advantage over placebo on any clinical measure.
How It Works
The imidazole ring does most of the work. Because its pKa sits near 6, histidine can act as both acid and base at body pH — which is what makes it a buffer and what puts it in the catalytic site of a large fraction of enzymes. The same ring chelates metals and participates in redox chemistry, the basis of the antioxidant and iron-handling claims.
From there, histidine branches into two named products:
Histamine, via histidine decarboxylase — the mediator of allergic and immune signalling, a stimulus for gastric acid, and a CNS neurotransmitter.
Carnosine, by joining with β-alanine — the dipeptide concentrated in muscle and brain that
buffers acid and scavenges reactive carbonyls. Note the direction of the bottleneck: β-alanine
limits this reaction, not histidine 9,
Two less obvious ones. In skin, histidine is incorporated into filaggrin, whose breakdown releases it again as a “natural moisturising factor” — the rationale for the eczema trials. And in adipose tissue it suppresses NF-κB-driven TNF-α and IL-6, which is the proposed route for the metabolic effects.
The full trial record is in Pharmacology & Research below.
Pharmacology & Research
L-Histidine is an essential (indispensable) amino acid whose imidazole side chain — able to gain or lose a proton near physiological pH — makes it a workhorse in enzyme active sites, pH buffering, and metal handling. Most of its decision-relevant biology is nutritional and biochemical rather than that of a standalone drug: it is the direct precursor to histamine and a building block of the muscle dipeptide carnosine. The honest through-line across the evidence is a repletion-versus-extra distinction — histidine matters most where plasma levels are low (obesity with metabolic syndrome, chronic kidney disease), and much weaker where people are already replete. Standalone supplementation is uncommon, doses studied cluster around 4 g/day, and the strongest human signals come from a small number of trials rather than a deep, replicated literature.
Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric. Each application links down to its write-up.
The single best human trial: a randomised, double-blind, placebo-controlled study in 100 obese women (aged 33–51, BMI ≥ 28) with metabolic syndrome, given 4 g/day L-histidine or placebo for 12 weeks 2Reference 2RCTHistidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome — randomised controlled trialView study →.
Versus placebo, histidine significantly reduced HOMA-IR (−1.09, 95% CI −1.49 to −0.68), BMI (−0.86 kg/m²), waist circumference (−2.86 cm), fat mass (−2.71 kg) and non-esterified fatty acids, alongside lower TNF-α and IL-6 and higher antioxidant enzyme activity and adiponectin 2Reference 2RCTHistidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome — randomised controlled trialView study →.
A companion metabolomic analysis of the same cohort confirmed systemic shifts in amino-acid, lipid and glucose metabolism 3Reference 3RCTEffects of histidine supplementation on global serum and urine ¹H NMR-based metabolomics and serum amino acid profiles in obese women — randomized controlled studyView study →.
Importantly, these women had low baseline serum histidine, so the effect is best read as correcting a relative deficiency rather than a benefit for anyone.
Gap: one trial, one narrow population (obese women with low baseline histidine); no replication in men, in lean individuals, or in replete people, so generalisability is unproven.
Histidine is rapidly incorporated into the skin-barrier protein filaggrin, whose breakdown releases histidine as a “natural moisturising factor” — the rationale for supplementing it in atopic dermatitis, a condition marked by filaggrin deficits 4Reference 4l-Histidine supplementation in adults and young children with atopic dermatitis (eczema) — clinical pilot studiesView study →.
In a placebo-controlled adult pilot (n=24), 4 g/day for 8 weeks cut SCORAD severity scores by 34% (P < 0.003) by week 4, and a children’s pilot (n=49, mean age 3.5 years) on 0.8 g/day reduced eczema area-and-severity scores by 49% (P < 0.02) at 12 weeks. A supporting open study reported effects comparable to mid-potency topical corticosteroids with a benign safety profile 4,
No adverse events were causally attributed to histidine.
Gap: these are small, short pilot studies from a closely related research group; a large, independent confirmatory RCT is still lacking.
In chronic kidney disease, plasma histidine tends to run low, and in a cohort of CKD patients low histidine was associated with protein-energy wasting, inflammation, oxidative stress, and greater mortality 6Reference 6ObservationalConsequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality — cohortView study →.
Mechanistically, histidine supports globin synthesis and erythropoiesis, may enhance dietary iron absorption, and — through its imidazole ring — scavenges free radicals and chelates iron, which is the basis for proposing it against iron-overload oxidative damage in the anemia of CKD 7Reference 7ReviewProtective role of histidine supplementation against oxidative stress damage in the management of anemia of chronic kidney disease — reviewView study →.
This is why histidine is included in some renal and dialysis nutrition formulas.
Gap: the human evidence is observational (association, not causation) and the protective case is mechanistic or preclinical — the benefit is contingent on pre-existing deficiency, not a general effect.
The imidazole ring lets histidine act as a metal chelator and radical scavenger, and this chemistry underlies most “antioxidant” claims 1Reference 1ReviewHistidine metabolism and function — reviewView study →.
Supporting signals are indirect: within the metabolic-syndrome RCT, histidine raised superoxide dismutase and glutathione peroxidase activity 2Reference 2RCTHistidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome — randomised controlled trialView study →, and an animal model showed histidine blunting high-salt-induced hepatic oxidative stress 13Reference 13Metabolomics reveals the defense mechanism of histidine supplementation on high-salt exposure-induced hepatic oxidative stress — animalView study →.
Much of the antioxidant story is really carnosine’s — the histidine-containing dipeptide is the prime bioactive form in muscle and brain, with histidine as its precursor 9,
Gap: no human trial has tested histidine as a standalone antioxidant against clinical endpoints; the evidence is mechanistic, animal, or a secondary marker within another trial.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| Histidine decarboxylase → histamine | Produces histamine (immune/allergic signalling, gastric acid, CNS neurotransmitter) | Allergicinflammatory and gastric physiology |
| Carnosine synthase (histidine + β-alanine → carnosine) | Builds the muscle and brain buffering / anti-glycation dipeptide (β-alanine rate-limiting) | Muscle bufferingantioxidant defence |
| Imidazole ring: metal chelation + redox | Chelates iron and divalent metals, scavenges radicals | Antioxidant supportCKD iron overload |
| NF-κB / pro-inflammatory cytokines | Suppressed TNF-α and IL-6 in adipocytes | Insulin resistancemetabolic syndrome |
| Filaggrin incorporation → natural moisturising factor | Augments skin-barrier hydration | Atopic dermatitis |
| Histidine ammonia-lyase → urocanate | Skin trans→cis-urocanate under UV (photoprotective) | Skin physiology |
Pharmacokinetics
Histidine is absorbed in the small intestine via active amino-acid transport and enters the free amino-acid pool; the WHO/FAO adult requirement is approximately 10 mg·kg⁻¹·d⁻¹ 1Reference 1ReviewHistidine metabolism and function — reviewView study →. Surplus histidine is catabolised in liver and skin — first to trans-urocanate by histidase, with complete hepatic breakdown requiring folate at the final glutamate formiminotransferase step, so folate status interacts with histidine handling (the basis of the historical FIGLU test) 1Reference 1ReviewHistidine metabolism and function — reviewView study →. It is also drawn off into histamine, via histidine decarboxylase, and into carnosine, with β-alanine. No distinctive elimination half-life is defined for supplemental histidine: it behaves as a dietary amino acid, and supplementation raises serum histidine and shifts related amino-acid pools within weeks 3Reference 3RCTEffects of histidine supplementation on global serum and urine ¹H NMR-based metabolomics and serum amino acid profiles in obese women — randomized controlled studyView study →.
Clinical trials
L-histidine appears in a large number of registry records, but the majority use it as a buffer or excipient in biologic drug formulations rather than as an oral nutritional intervention. Genuine oral-histidine supplementation trials are relatively few and cluster in dermatology, metabolic and renal nutrition. As an off-patent amino acid there is little commercial incentive for large confirmatory trials.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| ~10–15oral-supplement studies (many more list histidine as a formulation buffer) | Several | A few | Extensive(carnosine/antioxidant models) |
Last checked: August 2026.
Dietary Sources
Histidine is supplied by ordinary dietary protein, so frank deficiency is rare in people eating adequate protein. It is concentrated in animal proteins and also present in legumes, whole grains, nuts and seeds. Refining grains — removing the bran and germ — lowers the histidine content of cereal foods, and cooking losses are modest. Because it is embedded in food protein, dietary histidine is well absorbed as part of normal protein digestion.
| Food (per ~100 g) | Approx. histidine |
|---|---|
| Chicken / turkey breast | ~0.9–1.1 g |
| Beef / pork | ~0.8–1.0 g |
| Tuna / salmon | ~0.7–0.9 g |
| Soybeans (cooked) / tofu | ~0.3–0.5 g |
| Eggs | ~0.3 g |
| Whole grains, nuts, seeds | ~0.2–0.4 g |
Amounts are approximate and depend on the protein content of the food.
The WHO/FAO adult requirement is about 10 mg/kg/day 1Reference 1ReviewHistidine metabolism and function — reviewView study → — roughly 0.7 g for a 70 kg adult — readily met by typical protein intakes.
Intake & Dosage
These are doses studied in research, not a personal recommendation.
The physiological requirement is small (≈10 mg/kg/day, roughly 0.7 g/day for a 70 kg adult) and is normally met from food 1Reference 1ReviewHistidine metabolism and function — reviewView study →. No Tolerable Upper Intake Level has been set, and “no UL” should not be read as “unlimited is safe.”
Standalone supplemental doses in the literature fall in the 0.5–4 g/day range:
- 4 g/day — the metabolic-syndrome RCT and the adult atopic-dermatitis pilot 2,
4Reference 2RCTHistidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome — randomised controlled trialView study →Reference 4l-Histidine supplementation in adults and young children with atopic dermatitis (eczema) — clinical pilot studiesView study → . - 0.8 g/day — the children’s eczema pilot 4Reference 4l-Histidine supplementation in adults and young children with atopic dermatitis (eczema) — clinical pilot studiesView study →.
- 4.5 g/day — the rheumatoid-arthritis trial, which was negative 8Reference 8RCTTreatment of rheumatoid arthritis with L-histidine: a randomized, placebo-controlled, double-blind trialView study →.
Histidine also appears at lower per-serving amounts within broader essential-amino-acid blends. Appropriate intake depends on individual circumstances and is best confirmed with a qualified practitioner.
Safety
At dietary levels, and at the supplemental doses studied — up to about 4–4.5 g/day for 8 to 30 weeks
— L-histidine has been well tolerated, with no adverse events causally attributed to it in the
atopic-dermatitis and rheumatoid-arthritis trials 4,
- Well tolerated at studied doses. No adverse events were causally attributed to histidine in trials running 8–30 weeks at up to 4.5 g/day 4,
8Reference 4l-Histidine supplementation in adults and young children with atopic dermatitis (eczema) — clinical pilot studiesView study →Reference 8RCTTreatment of rheumatoid arthritis with L-histidine: a randomized, placebo-controlled, double-blind trialView study → . - Increases urinary zinc loss. Histidine binds zinc and raises its renal ultrafilterability, so high chronic supplemental intake can erode zinc status over time 11Reference 11Nutrient interactions with total parenteral nutrition: effect of histidine and cysteine intake on urinary zinc excretionView study →.
- Medical supervision in kidney disease. Histidine handling is altered in renal impairment — which is precisely why it is used clinically in that setting.
- Folate interacts with histidine catabolism. Complete hepatic breakdown requires folate at the final step 1Reference 1ReviewHistidine metabolism and function — reviewView study →.
- Theoretical histamine-load caution. Histidine is the histamine precursor; the relevance for histamine-sensitive people is not well quantified for oral dosing.
- No upper limit is set. Absence of a UL does not imply high intakes are safe.
Full Safety & Interactions Detail
The best-characterised concern is a mineral interaction: histidine binds zinc and increases its renal ultrafilterability, raising urinary zinc excretion. This was demonstrated where histidine intake was elevated — parenteral-nutrition and supplementation contexts — so high, chronic supplemental intake can erode zinc status over time 11Reference 11Nutrient interactions with total parenteral nutrition: effect of histidine and cysteine intake on urinary zinc excretionView study →. Anyone supplementing histidine long-term should consider zinc status alongside it.
- Kidney disease: people with chronic kidney disease or renal impairment should use supplemental histidine only under medical supervision, since it is used clinically in that setting precisely because handling is altered.
- Folate: complete hepatic catabolism of histidine requires folate at the glutamate formiminotransferase step, so folate status interacts with histidine handling 1Reference 1ReviewHistidine metabolism and function — reviewView study →.
- Histamine: because histidine is the precursor to histamine, a theoretical caution exists for histamine-sensitive individuals, though this is not well quantified for oral histidine.
Scope disclosure. Interactions were assessed: the main one is zinc 11Reference 11Nutrient interactions with total parenteral nutrition: effect of histidine and cysteine intake on urinary zinc excretionView study →, with folate interacting with catabolism 1Reference 1ReviewHistidine metabolism and function — reviewView study → and a theoretical histamine-load caution. No systematic drug-interaction database review was performed. Pregnancy and lactation were assessed only partially — no trials establish a safe supplemental dose, though dietary intake is normal. No Upper Limit has been set, and absence of one does not imply high intakes are safe. Where something was not studied, it is marked “not assessed,” not “safe.”
Dietary intake is normal and expected; supplements are not established. Dietary histidine is an ordinary part of protein intake in pregnancy. Supplemental histidine above dietary levels has not been established as safe in pregnancy or lactation — no adequate trials define a safe supplemental dose — and is best avoided without professional guidance.
References
- Brosnan ME, Brosnan JT (2020). Histidine metabolism and function — review. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/33000155/
- Feng RN, et al. (2013). Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome — randomised controlled trial. Diabetologia. https://pubmed.ncbi.nlm.nih.gov/23361591/
- Du S, et al. (2017). Effects of histidine supplementation on global serum and urine ¹H NMR-based metabolomics and serum amino acid profiles in obese women — randomized controlled study. Journal of Proteome Research. https://pubmed.ncbi.nlm.nih.gov/28447460/
- Gibbs NK (2020). l-Histidine supplementation in adults and young children with atopic dermatitis (eczema) — clinical pilot studies. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/33000160/
- Tan SP, et al. (2017). Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis. Clinical, Cosmetic and Investigational Dermatology. https://pubmed.ncbi.nlm.nih.gov/29042806/
- Watanabe M, et al. (2008). Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality — cohort. American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/18541578/
- Vera-Aviles M, et al. (2018). Protective role of histidine supplementation against oxidative stress damage in the management of anemia of chronic kidney disease — review. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/30347874/
- Pinals RS, et al. (1977). Treatment of rheumatoid arthritis with L-histidine: a randomized, placebo-controlled, double-blind trial. The Journal of Rheumatology. https://pubmed.ncbi.nlm.nih.gov/342692/
- Boldyrev AA, et al. (2013). Physiology and pathophysiology of carnosine — review. Physiological Reviews. https://pubmed.ncbi.nlm.nih.gov/24137022/
- Perim P, et al. (2019). Can the skeletal muscle carnosine response to beta-alanine supplementation be optimized? — review. Frontiers in Nutrition. https://pubmed.ncbi.nlm.nih.gov/31508423/
- Zlotkin SH (1989). Nutrient interactions with total parenteral nutrition: effect of histidine and cysteine intake on urinary zinc excretion. The Journal of Pediatrics. https://pubmed.ncbi.nlm.nih.gov/2497237/
- Song BC, et al. (2014). Biological functions of histidine-dipeptides and metabolic syndrome — review. Nutrition Research and Practice. https://pubmed.ncbi.nlm.nih.gov/24611099/
- Yang P, et al. (2023). Metabolomics reveals the defense mechanism of histidine supplementation on high-salt exposure-induced hepatic oxidative stress — animal. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/36596407/
